Ariad's "Poison Pill" Plan Comes After Former Icahn Exec Buys Stake

Business News Nov 4 2013 BoardNews

Investors seem boyed by Ariad Pharmaceuticals’ decision Friday to adopt a plan designed to prevent takeovers, raising the company’s stock price 22 percent since the Friday morning announcement...

Read Full Article

Bookmark or Share this article

Login to comment.

Agios Scores Biogen CFO as Board Member also written by Don Seiffert
Corporate Boards: Shifting From Aging Men To New Generation Of Women? also categorized in BoardNews
Verastem directors buy $475K of stock, company set for potential pivotal trials also written by Don Seiffert
New Baxter CEO Steps Down From EMC Board also published in Business News
Getting Gen-Y on Boards (of Directors) also categorized in BoardNews
The Other Duty of Corporate Governance also categorized in BoardNews
Netflix: Icahn Says Poison Pill 'Poor Corporate Governance' also categorized in BoardNews
Have the Swiss Gone Cuckoo? also categorized in BoardNews
Six Years Later, The Problem at HP is Still the Board also categorized in BoardNews
Taiwan Court Orders Reinstatement Of Two CPDC Board Candidates As Contested Vote Nears also categorized in BoardNews

Ariad's "Poison Pill" Plan Comes After Former Icahn Exec Buys Stake

Login to comment.

Related Articles

Topics Mentioned

Authors

Ariad's "Poison Pill" Plan Comes After Former Icahn Exec Buys Stake

Login to comment.

Related Articles

Categories

BoardProspects Features:

Topics Mentioned

Authors